Effect of Unani Medicine in vitiligo patients with the help of Biomarkers
Phase 2
- Conditions
- Health Condition 1: L80- Vitiligo
- Registration Number
- CTRI/2023/07/055901
- Lead Sponsor
- Central Council for research in Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with clinically diagnosed non-dermatomal progressive vitiligo
18-50 years of Age
Any gender
With any duration of disease, site, extension and distribution of lesions
Willingness to written informed consent form
Exclusion Criteria
Patients having Dermatomal vitiligo
Pregnant and lactating mother
Patients having hepato-renal, cardiac and pulmonary disorders
Patients on active vitiligo treatment with other drugs
Subjects with other skin disease having known allergies
Subjects those who are unwilling to come regular follow ups for the entire duration of study
Non-cooperative patients / Non treatment compliance.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method